Qube Research & Technologies (QRT)’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-165,367
| Closed | -$169K | – | 3103 |
|
|
2024
Q4 | $169K | Buy |
+165,367
| New | +$169K | ﹤0.01% | 2240 |
|
|
2024
Q3 | – | Sell |
-199,788
| Closed | -$71.6K | – | 3489 |
|
|
2024
Q2 | $71.6K | Buy |
+199,788
| New | +$71.6K | ﹤0.01% | 2299 |
|
|
2024
Q1 | – | Sell |
-4,533
| Closed | -$2.46K | – | 4251 |
|
|
2023
Q4 | $2.46K | Sell |
4,533
-1,172
| -21% | -$637 | ﹤0.01% | 3374 |
|
|
2023
Q3 | $3.42K | Sell |
5,705
-284,009
| -98% | -$170K | ﹤0.01% | 3070 |
|
|
2023
Q2 | $377K | Sell |
289,714
-551,546
| -66% | -$717K | ﹤0.01% | 1522 |
|
|
2023
Q1 | $1.48M | Buy |
841,260
+620,577
| +281% | +$1.09M | 0.01% | 1075 |
|
|
2022
Q4 | $693K | Buy |
220,683
+135,890
| +160% | +$427K | ﹤0.01% | 1291 |
|
|
2022
Q3 | $415K | Buy |
84,793
+9,373
| +12% | +$45.9K | ﹤0.01% | 1486 |
|
|
2022
Q2 | $312K | Buy |
75,420
+6,986
| +10% | +$28.9K | ﹤0.01% | 1565 |
|
|
2022
Q1 | $398K | Buy |
+68,434
| New | +$398K | ﹤0.01% | 1624 |
|
|
2021
Q4 | – | Sell |
-22,012
| Closed | -$198K | – | 2920 |
|
|
2021
Q3 | $198K | Buy |
+22,012
| New | +$198K | ﹤0.01% | 1662 |
|
|
2021
Q1 | – | Sell |
-24,452
| Closed | -$382K | – | 2356 |
|
|
2020
Q4 | $382K | Sell |
24,452
-3,577
| -13% | -$55.9K | 0.01% | 1250 |
|
|
2020
Q3 | $265K | Sell |
28,029
-17,977
| -39% | -$170K | ﹤0.01% | 1288 |
|
|
2020
Q2 | $412K | Buy |
+46,006
| New | +$412K | 0.01% | 1190 |
|